MedPath
HSA Approval

BEATACYCLINE CAPSULE 250 mg

SIN02053P

BEATACYCLINE CAPSULE 250 mg

BEATACYCLINE CAPSULE 250 mg

June 24, 1988

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01AA07

tetracycline

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

TETRACYCLINE HYDROCHLORIDE

250 mg

Tetracycline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEATACYCLINE CAPSULE 250 mg - HSA Approval | MedPath